IMA is loading

Main Financial Data 2011

Main Data: 31/12 Year 2011
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 669.21
– gross industrial income 270.11
– total operating cost 203.61
– operating profit 66.50
– net financial expenses 10.94
– group profit 27.99

 

Consolidated balance sheet Millions/Euro
– working capital 82.65
– non-current assets 244.07
– provision for severance indemnities and other provisions – 20.30
– net debt – 157.50
– equity pertaining to the group and minority interests 148.92

 

Other information Millions/Euro
– depreciation, amortization and impairment 19.99
– R & D costs 29.07

 

  Euro
Dividend per share 1.00

 

  No.
Employees 3,469

 

  Euro
Share capital 19,150,560

 

Main Data: 30/06 Year 2011
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 278.0
– gross industrial income 109.9
– total operating cost 100.9
– operating profit 9.0
– net financial expenses 5.0
– group profit (loss) 1.0

 

Consolidated balance sheet Millions/Euro
– working capital 91.3
– non-current assets 239.5
– provision for severance indemnities and other provisions – 22.4
– net debt – 190.6
– equity pertaining to the group and minority interests 117.8

 

Other information Millions/Euro
– depreciation, amortization and impairment 9.2
– R & D costs 15.1

 

  No.
Employees 3,408

 

  Euro
Share capital 19,150,560

 

Net Sales by Sector: Year 2011
  Millions/Euro  
tea, food & other 259.81 38.8%
pharmaceutical 409.40 61.2%
Total 669.21 100.0%

 

Net Sales by Country: Year 2011
  Millions/Euro  
E.U. (excluding Italy) 246.09 36.8%
Other European countries 41.34 6.2%
North America 96.35 14.4%
Asia & Middle East 155.57 23.2%
Other countries 71.61 10.7%
Total exports 610.96 91.3%
Italy 58.25 8.7%
Total 669.21 100.0%
Dismissclose

Relive
Achema

The exclusive tech videos shot during Achema 2024 are now available on our dedicated website